← Russell 3000 cross-section

HSTM HEALTHSTREAM INC

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Technology

Scale

Market cap
$850m
Revenue TTM
$321m
Net income TTM
$21m
Free cash flow
$70m
Composite score
58.7
Sector rank
#2116

Valuation

P / E
40.1
EV / EBITDA
11.1
EV / sales
2.4
FCF yield
8.22%
Earnings yield vs 10-yr
-2.23pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
6.6%
EBITDA margin
21.9%
ROE
5.9%
ROIC
8.9%
Revenue growth
8.8%

Insider activity, last 90 days

Net open-market
$-0.27m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Revenues increased $9.3 million, or 13%, to $83.7 million for the three months ended June 30, 2026 from $74.4 million for the three months ended June 30, 2025. Subscription revenues increased by $8.0 million, or 11%, and professional services revenues increased by $1.3 million compared to the second quarter of 2025. Cost of revenues increased $2.7 million, or 10%, to $29.0 million for the three months ended June 30, 2026, from $26.4 million for the three months ended June 30, 2025. Product development expenses increased $1.5 million, or 12%, to $13.6 million for the three months ended June 30, 2026, from $12.1 million for the three months ended June 30, 2025. …HEALTHSTREAM INC, 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →